isocitric acid has been researched along with Carcinoma, Embryonal in 1 studies
isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.
Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asanagi, M | 1 |
Yamada, S | 1 |
Hirata, N | 1 |
Itagaki, H | 1 |
Kotake, Y | 1 |
Sekino, Y | 1 |
Kanda, Y | 1 |
1 other study available for isocitric acid and Carcinoma, Embryonal
Article | Year |
---|---|
Tributyltin induces G2/M cell cycle arrest via NAD(+)-dependent isocitrate dehydrogenase in human embryonic carcinoma cells.
Topics: Apigenin; Carcinoma, Embryonal; cdc25 Phosphatases; Cell Line, Tumor; Cyclin B1; Endocrine Disruptor | 2016 |